Interview: Bart Roep – Director, Diabetes Expert Center, Leiden…
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Address: Albinusdreef 2, 2333 ZA Leiden, the Netherlands
,Netherlands
Tel: +31 71 5269111
Web: https://www.lumc.nl/home/
One of the eight medical centres in the Netherlands, the Leiden University Medical Center (LUMC) has five core tasks:
patient care
scientific research
education
study programmes
continuing education.
The LUMC employs 7000 people.
Patient care is largely focused on highly specialised care, the sort of care that cannot be provided anywhere else. The LUMC also offers a broad package of top-level clinical care, including organ transplants, cardiovascular interventions and all types of bone marrow transplants.
The research conducted in the LUMC is both fundamental and patient- and care-oriented. A considerable portion of the research centres on the translation from fundamental research to its use in patient care (from bench to bedside and vice versa). A good example is the recently opened C.J. Gorter Center, one of the world’s prominent centres in the area of MRI research.
The C.J. Gorter Center has installed the first 7Tesla MRI scanner in the Netherlands for use with humans. The research in the LUMC will be aimed at early diagnosis of Alzheimer’s, a better understanding of migraine, the energy economy in healthy people and patients with diabetes, and the process of ageing. Important research themes in the LUMC are: ageing, neurosciences, vascular medicine, infectious diseases and immunology, cancer immunotherapy, regenerative medicine, oncogenetics, genetic epidemiology and bio-informatics.
The LUMC offers degree courses in Medicine and Biomedical Sciences. The training of medical specialists is also a core task of the LUMC. Medical specialists are trained in 27 specialities in collaborative clusters of general hospitals in the vicinity.
The Boerhaave Committee is another part of the LUMC. Its focus is the provision of high-quality training at post-academic and post-graduate as well post-vocational levels.
patient care
scientific research
education
study programmes
continuing education
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive…
In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in the Netherlands? OTC medicines…
How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to operate from the committee perspective, or is there an annual…
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
A very strong phrase that we recently came across describes a “war going on in the generics industry” as a result of the preference policy, which people have claimed has…
Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined in 2007. What made this combination…
Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a…
We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to…
See our Cookie Privacy Policy Here
